Current Gene Therapy

Ignacio Anegon
Director INSERM UMR 1064-Center for Research in Transplantation and Immunology
CHU de Nantes. 30, boulevard
Nantes
France

Back

Ahead of Print Article(s)

CRISPR/Cas9 Editing to Facilitate and Expand Drug Discovery

Volume:17
Francis Robert, Sidong Huang and Jerry Pelletier*

The Progress of Gene Therapy for Leber's Optic Hereditary Neuropathy

Volume:18
Yong Zhang, Zhen Tian, Jiajia Yuan, Chang Liu, Hong li Liu, Si Qi Ma and Bin Li*

Therapeutic Applications of CRISPR/Cas for Duchenne Muscular Dystrophy

Volume:17
Tatianna Wai Ying Wong and Ronald D. Cohn*

CRISPR/Cas9 Gene Editing: From Basic Mechanisms to Improved Strategies for Enhanced Genome Engineering In Vivo

Volume:17
Jayme Salsman, Jean-Yves Masson, Alexandre Orthwein and Graham Dellaire*